Compare MDXG & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDXG | CSR |
|---|---|---|
| Founded | 2006 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | MDXG | CSR |
|---|---|---|
| Price | $7.07 | $67.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $11.00 | ★ $70.50 |
| AVG Volume (30 Days) | ★ 741.2K | 208.3K |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.27 | ★ 1.82 |
| Revenue | ★ $393,442,000.00 | $273,450,000.00 |
| Revenue This Year | $19.13 | $6.83 |
| Revenue Next Year | $2.11 | $3.14 |
| P/E Ratio | ★ $25.92 | $36.59 |
| Revenue Growth | ★ 14.77 | 5.72 |
| 52 Week Low | $5.79 | $52.76 |
| 52 Week High | $9.71 | $69.15 |
| Indicator | MDXG | CSR |
|---|---|---|
| Relative Strength Index (RSI) | 51.32 | 60.76 |
| Support Level | $6.91 | $64.01 |
| Resistance Level | $7.45 | $67.14 |
| Average True Range (ATR) | 0.24 | 1.98 |
| MACD | 0.01 | 0.16 |
| Stochastic Oscillator | 53.50 | 88.31 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.